Stereotactic Body Radiotherapy for Localized Low-Intermediate Risk Prostate Cancer

被引：0
|
作者：
Haas, J. [1 ]
Santoro, M. [1 ]
Ashley, R. [2 ]
Mucciolo, R. [1 ]
Andrews, J. [1 ]
Clancey, O. [1 ]
Episcopia, K. [1 ]
Accordino, D. [1 ]
Sanchez, A. [1 ]
Witten, M. [1 ]
机构：
[1] Winthrop Univ Hosp, Mineola, NY 11501 USA
[2] N Shore Univ Hosp, Manhasset, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.712
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S432 / S432
页数：1
相关论文
共 50 条
  • [1] Stereotactic Body Radiation Therapy for Low-Intermediate Risk Prostate Cancer
    Haas, J.
    Katz, A. E.
    Santoro, M.
    Ashley, R.
    Mucciolo, R.
    Kessaris, D.
    Andrews, J.
    Clancey, O.
    Sanchez, A.
    Witten, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S361 - S361
  • [2] Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer
    Kishan, Amar U.
    King, Christopher R.
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2017, 27 (03) : 268 - 278
  • [3] Stereotactic ablative radiotherapy for low to intermediate risk prostate cancer
    Sadozye, A.
    Dodds, D.
    MacLeod, N.
    Lamb, C.
    Smith, S.
    Foster, J.
    Devlin, L.
    Dufton, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S679 - S680
  • [4] Extracranial stereotactic radiotherapy in low and favourable intermediate risk prostate cancer
    Navarro Aznar, V.
    Mendez Villamon, A.
    Puertas Valino, M. D. M.
    Garcia Aguilera, C.
    Cerrolaza Pascual, M.
    Lanuza Pascual, A.
    Ponce Ortega, J. M.
    Colom, C.
    Garcia Gimeno, B.
    Tejedor Gutierrez, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1217 - S1218
  • [5] LOW-INTERMEDIATE RISK PROSTATE CANCER TREATED WITH CYBERKNIFE-DELIVERED HYPOFRACTIONATED RADIOTHERAPY
    Scremin, E.
    Tambone, C.
    Bolzicco, G.
    Favretto, M. S.
    D'Amato, G.
    Ferrarese, P.
    Abatangelo, G.
    Nigro, F.
    Tasca, A.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 52 - 52
  • [6] Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review
    Arcangeli, Stefano
    Scorsetti, Marta
    Alongi, Filippo
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 84 (01) : 101 - 108
  • [7] Treatment options in low-intermediate risk prostate cancer
    Eskicorapci, Saadettin Yilmaz
    Bolat, Deniz
    [J]. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (02): : 80 - 85
  • [8] Stereotactic body radiotherapy for low and intermediate risk prostate cancer: Four-year outcomes.
    Potharaju, Mahadev
    Ravishankar, L. S.
    Sasikumar, Neetu
    Sadiq, A. L., I
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] CLINICAL RESULTS IN HYPOFRACTIONATED STEREOTACTIC BODY RADIATION THERAPY (SBRT) FOR LOW-INTERMEDIATE PROSTATE CANCER.
    Bolzicco, G.
    Favretto, M. S.
    Scremin, E.
    Tambone, C.
    Tasca, A.
    Guglielmi, R.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S396 - S397
  • [10] MR-guided laser focal therapy for low-intermediate risk localized prostate cancer
    Lindner, U.
    Davidson, S. R. H.
    Haider, M. A.
    Hlasny, E.
    Gertner, M. R.
    Wilson, B. C.
    Kucharczyk, W.
    Trachtenberg, J.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E15 - U320
12345